Venus Medtech Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
557
- Stock Symbol
-
02500
- Investments
-
10
- Share Price
-
$0.13
- (As of Friday Closing)
Venus Medtech General Information
Description
Venus Medtech (Hangzhou) Inc is engaged in the medical devices that integrate R&D, clinical development, manufacturing, and commercialization. The company has developed a product portfolio covering the interventional devices for valvular heart diseases, including transcatheter aortic valve replacement (TAVR), transcatheter pulmonary valve replacement (TPVR), transcatheter mitral valve replacement (TMVR), transcatheter tricuspid valve replacement (TTVR), and other procedural accessories, allowing it to provide overall solutions for physicians and patients. Geographically, the company operates in mainland China, Israel, Hong Kong, the USA, and the Netherlands. The majority of the revenue is derived from Mainland China.
Contact Information
Website
www.venusmedtech.comCorporate Office
- Room 311, 3/F, Block 2
- No. 88, Jiangling Road, Binjiang District
- Hangzhou, Zhejiang
- China
Corporate Office
- Room 311, 3/F, Block 2
- No. 88, Jiangling Road, Binjiang District
- Hangzhou, Zhejiang
- China
Venus Medtech Stock Performance
As of 13-Nov-2026, Venus Medtech’s stock price is $0.13. Its current market cap is $55.3M with 438M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.13 | $0.13 | $0.12 - $0.49 | $55.3M | 438M | 607K | -$0.15 |
Venus Medtech Financials Summary
As of 30-Jun-2026, Venus Medtech has a trailing 12-month revenue of $36.5M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 40,581 | 163,053 | 320,490 | 238,192 |
| Revenue | 36,463 | 42,661 | 65,617 | 69,453 |
| EBITDA | (50,547) | (40,989) | (86,866) | (82,304) |
| Net Income | (66,343) | (56,692) | (99,549) | (99,472) |
| Total Assets | 327,276 | 360,097 | 445,168 | 622,650 |
| Total Debt | 29,832 | 8,880 | 50,559 | 116,551 |
Venus Medtech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Venus Medtech Comparisons
Industry
Financing
Details
Venus Medtech Competitors (36)
One of Venus Medtech’s 36 competitors is Medtronic, a Corporation company based in Minneapolis, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Medtronic | Corporation | Minneapolis, MN | ||||
| DUKE Empirical | Private Equity-Backed | Morgan Hill, CA | ||||
| Artivion | Formerly PE-Backed | Kennesaw, GA | ||||
| Asensus Surgical | Formerly VC-backed | Durham, NC | ||||
| Edwards Lifesciences | Corporation | Irvine, CA |
Venus Medtech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Venus Medtech Patents
Venus Medtech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4837538-A1 | Artificial implant, interventional system, and method for driving blocking member on artificial implant to deform | Pending | 30-Dec-2024 | ||
| WO-2026138894-A1 | Interventional system for artificial implant | Pending | 27-Dec-2024 | ||
| WO-2025146007-A1 | Artificial implant, interventional system, and method for driving blocking member on artificial implant to deform | Inactive | 02-Jan-2024 | ||
| EP-4834285-A1 | Delivery system for artificial implant | Pending | 29-Dec-2023 | ||
| US-20260354973-A1 | Delivery system for artificial implant | Pending | 29-Dec-2023 | A61F2/2436 |
Venus Medtech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Venus Medtech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Venus Medtech Investments & Acquisitions (10)
Venus Medtech’s most recent deal was a Merger/Acquisition with Cardiovalve for . The deal was made on 25-Jan-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cardiovalve | 25-Jan-2022 | Merger/Acquisition | Therapeutic Devices | ||
| Nuocheng Medical | 02-Nov-2021 | Merger/Acquisition | Distributors (Healthcare) | ||
| AtomSemi | 01-Nov-2021 | Early Stage VC | General Purpose Semiconductors | ||
| Zenus Tech | 25-Oct-2021 | Early Stage VC | Multimedia and Design Software | ||
| Valgen Medtech | 06-May-2021 | Later Stage VC | Surgical Devices |
Venus Medtech ESG
Risk Overview
Risk Rating
Updated April, 30, 2024
33.82 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,088
Rank
Percentile
Healthcare
Industry
of 636
Rank
Percentile
Medical Devices
Subindustry
of 225
Rank
Percentile
Venus Medtech Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Nuocheng Medical | Hangzhou, China | 2017 | |
| Cardiovalve | Or Yehuda, Israel | 2010 |
Venus Medtech FAQs
-
When was Venus Medtech founded?
Venus Medtech was founded in 2009.
-
Where is Venus Medtech headquartered?
Venus Medtech is headquartered in Hangzhou, China.
-
What is the size of Venus Medtech?
Venus Medtech has 557 total employees.
-
What industry is Venus Medtech in?
Venus Medtech’s primary industry is Therapeutic Devices.
-
Is Venus Medtech a private or public company?
Venus Medtech is a Public company.
-
What is Venus Medtech’s stock symbol?
The ticker symbol for Venus Medtech is 02500.
-
What is the current stock price of Venus Medtech?
As of 13-Nov-2026 the stock price of Venus Medtech is $0.13.
-
What is the current market cap of Venus Medtech?
The current market capitalization of Venus Medtech is $55.3M.
-
What is Venus Medtech’s current revenue?
The trailing twelve month revenue for Venus Medtech is $36.5M.
-
Who are Venus Medtech’s competitors?
Medtronic, DUKE Empirical, Artivion, Asensus Surgical, and Edwards Lifesciences are some of the 36 competitors of Venus Medtech.
-
What is Venus Medtech’s annual earnings per share (EPS)?
Venus Medtech’s EPS for 12 months was -$0.15.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
